ArticleEGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
ArticleEGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
ArticleFOX A1 expression as a prognostic factor in cases of invasive serous and mucinous ovarian carcinoma in association with p53 status and CEA expression
ArticleFOX A1 expression as a prognostic factor in cases of invasive serous and mucinous ovarian carcinoma in association with p53 status and CEA expression
ArticleImmunohistochemical Expression of SOX2 and EpCAM in Colorectal Cancer and its Precancerous lesions
ArticleImmunohistochemical Expression of SOX2 and EpCAM in Colorectal Cancer and its Precancerous lesions
ArticleEpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study
ArticleEpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study
ArticleOCT4, Ki-67 and VEGF as Prognostic Factors in Endometrial Carcinoma and Their Role in The Differentiation between Atypical Endometrial Hyperplasia and Grade 1 Endometrial Carcinom
ArticleOCT4, Ki-67 and VEGF as Prognostic Factors in Endometrial Carcinoma and Their Role in The Differentiation between Atypical Endometrial Hyperplasia and Grade 1 Endometrial Carcinom
ArticlePrognostic implications of glutathione perioxiade2 (GPx2) and the stemness associated marker SOX2 in colonic carcinoma
ArticlePrognostic implications of glutathione perioxiade2 (GPx2) and the stemness associated marker SOX2 in colonic carcinoma
ArticleStratification of Endometrial Carcinoma Patients Using Immunohistochemistry for Better Surgical Planning and Prognosis
ArticleStratification of Endometrial Carcinoma Patients Using Immunohistochemistry for Better Surgical Planning and Prognosis